Biotechnology company ImClone Systems Inc. said Wednesday that it is considering a buyout offer worth $70 per share from an unidentified large pharmaceutical company and rejected a $60-per-share ...

ImClone Systems Inc.'s high-water mark was a sweet deal last fall in which its shareholders were allowed to sell a portion of their holdings to drug giant Bristol-Myers Squibb Co. for $70 a share.

ImClone Officials Ordered Shredders. By Justin Gillis. September 14, 2002. Samuel and Harlan Waksal, the two brothers who ran ImClone Systems Inc., ordered shredders ...

NEW YORK — ImClone Systems’ board of directors said Monday cancer-drug partner Bristol-Myers Squibb’s $4.5 billion buyout offer “substantially undervalues” the company, with Chairman ...

Drugmaker Eli Lilly & Co. reportedly is the secret suitor that's been courting ImClone Systems Inc. and is offering about $6.1 billion for the biotech company.

Imclone Systems biopharmaceutical manufacturing facility in Branchburg was approved by the FDA in July 2002, according to pharmaceutical-technology.com. BRANCHBURG - A manufacturing operation at ...

BOSTON (CBS.MW) -- ImClone Systems announced Monday that it had filed its delayed annual report with regulators, a significant step toward regaining compliance with Nasdaq listing requirements ...

Sam Waksal, the founder of ImClone Systems who fell from grace before the company became $6.5 billion takeover property for Eli Lilly, is back in the biotech world, trying to raise $50 million for ...

Among the mysteries surrounding the implosion of ImClone Systems Inc. is the terrible timing of a $1.2-billion investment in the company by Bristol-Myers Squibb Co. The pharmaceutical giant ...

SAN FRANCISCO (CBS.MW) -- ImClone Systems has sued founder and former chief executive Sam Waksal for more than $21 million in accrued income taxes that the biotech company subsequently paid ...

Shares of ImClone Systems Inc. dropped nearly 18% Monday on worries that the launch of the company's crucial colorectal-cancer drug, Erbitux, may be delayed longer than expected. The setback also ...